Compare Cardinal Health Inc (CAH) vs Vanguard Total International Stock Index Fund ETF (VXUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Vanguard Total International Stock Index Fund ETF — how do they compare? Cardinal Health Inc trades at $229 (market cap $53.89B), while Vanguard Total International Stock Index Fund ETF trades at $84.84. The key difference: Cardinal Health Inc pays a 0.89% dividend while Vanguard Total International Stock Index Fund ETF pays none. Which is the better fit depends on your goals.
| CAH | VXUS | |
|---|---|---|
Market Cap | $53.89B | — |
Sector | Health | Sector/Thematic |
52-Week High | $239.71 | $87.06 |
52-Week Low | $146.04 | $68.24 |
Enterprise Value | $58.87B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
VXUS trades at $83.78, down 1.83% amid bearish technical signals, with moving averages indicating selling pressure and key support at $83. The ETF offers broad international equity exposure across 8,738 stocks, though financial ratios are unavailable. Recent news highlights its role in diversification as U.S. valuations remain elevated.
Outlook hinges on global economic shifts; VXUS provides cost-effective diversification but faces headwinds from inflation and U.S. dominance. Risks include currency fluctuations and emerging market volatility, while analysts note its discount to U.S. peers could offer long-term value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Vanguard Total International Stock Index Fund ETF
VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →
